Eduardo Bruera: Predictive Biomarkers and Placebo Response in Cancer Clinical Trial
Eduardo Bruera/mdanderson.org

Eduardo Bruera: Predictive Biomarkers and Placebo Response in Cancer Clinical Trial

Eduardo Bruera, Medical Doctor at MD Anderson Cancer Center, shared a post on LinkedIn:

“High baseline cytokines linked to reduced placebo response across multiple symptoms in cancer patients, with implications for clinical trial design.​​​​​​​​​​​​​​​​”

Title: Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial

Authors: David Hui, Kristofer Jennings, Amy Ontai, Sandra K. Hanneman, Eduardo Bruera

Read The Full Article

Eduardo Bruera

Other articles featuring Eduardo Bruera on OncoDaily.